Video

Dr. Awan on the Importance of FISH Testing in CLL

Farrukh Awan, MBBS, associate professor, The Ohio State University Comprehensive Cancer Center, discusses the importance of fluorescence in situ hybridization (FISH) testing for patients with chronic lymphocytic leukemia (CLL).

Farrukh Awan, MBBS, associate professor, The Ohio State University Comprehensive Cancer Center, discusses the importance of fluorescence in situ hybridization (FISH) testing for patients with chronic lymphocytic leukemia (CLL).

According to Awan, the most critical area in CLL is the underutilization of FISH and IGVH testing. That is essential to prognosticating patients and critical to selecting the right therapy.

Based on market data, this is not being done universally and it is an area that needs improvement, says Awan.

Related Videos
Ritu Salani, MD
Aaron Gerds, MD
Maximilian Stahl, MD
Abhirami Vivekanandarajah, MD
Balazs Halmos, MD
Balazs Halmos, MD
Ghayas C. Issa, MD
Albert Grinshpun, MD, MSc, head, Breast Oncology Service, Shaare Zedek Medical Center
Erica L. Mayer, MD, MPH, director, clinical research, Dana-Farber Cancer Institute; associate professor, medicine, Harvard Medical School